alphaveAJANTPHARM₹3,540.00

Ajanta Pharmaceuticals Ltd.

₹ CrorePeersALKEM IPCALAB TORNTPHARM ABBOTINDIA ANTHEM GLAXO MEDANTA GLENMARKMcap ₹44,374 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Non-current Assets
+ Property, Plant & Equipment	1,384.1	1,624.9	1,726.4	1,726.4
+ Capital Work-in-Progress	256.5	176.3	258.1	258.1
+ Other Intangibles	95.1	137.2	140.6	140.6
+ Non-current Investments	18.6	25.2	28.5	28.5
+ Other Non-current Financial Assets	9.4	9.3	8.0	8.0
Non-current Financial Assets	27.9	34.5	36.5	36.5
+ Deferred Tax Assets	134.5	186.4	188.6	188.6
+ Other Non-current Assets	9.4	12.7	69.3	69.3
Total Non-current Assets	1,907.5	2,171.9	2,419.4	2,419.4
Current Assets
+ Inventories	828.4	903.9	938.5	938.5
+ Current Investments	330.1	438.7	559.9	559.9
+ Trade Receivables	1,246.8	1,182.7	1,853.9	1,853.9
+ Cash & Cash Equivalents	129.5	175.1	103.3	103.3
+ Other Bank Balances	1.3	1.1	1.5	1.5
+ Short-term Loans	34.0	2.5	1.7	1.7
+ Other Current Financial Assets	19.0	2.3	9.0	9.0
Current Financial Assets	1,760.6	1,802.6	2,529.2	2,529.2
+ Other Current Assets	133.1	123.3	267.7	267.7
Total Current Assets	2,722.1	2,829.7	3,735.4	3,735.4
Total Assets	4,638.4	5,015.0	6,154.8	6,154.8
Equity
+ Equity Share Capital	25.3	25.1	25.1	25.1
+ Other Equity / Reserves	3,542.1	3,765.2	4,502.0	4,502.0
Equity — Owners of Parent	3,567.4	3,790.3	4,527.1	4,527.1
Total Equity	3,567.4	3,790.3	4,527.1	4,527.1
Liabilities
+ Other Non-current Financial Liab	24.9	35.8	41.2	41.2
Non-current Financial Liabilities	24.9	35.8	41.2	41.2
+ Provisions — Non-current	39.5	80.3	51.2	51.2
+ Deferred Tax Liabilities	108.5	110.5	117.9	117.9
+ Other Non-current Liabilities	2.3	2.0	1.7	1.7
Non-current Liabilities	175.3	228.6	212.0	212.0
+ Borrowings — Current	1.5	2.6	212.0	212.0
+ Trade Payables	463.2	454.2	544.3	544.3
+ Other Current Financial Liab	308.3	384.3	504.6	504.6
Current Financial Liabilities	773.0	841.1	1,260.9	1,260.9
+ Provisions — Current	17.8	23.4	30.4	30.4
+ Current Tax Liabilities	44.8	40.5	5.5	5.5
+ Other Current Liabilities	59.7	91.1	119.0	119.0
Current Liabilities	895.3	996.1	1,415.8	1,415.8
Total Liabilities	1,071.0	1,224.7	1,627.8	1,627.8
Total Equity & Liabilities	4,638.4	5,015.0	6,154.8	6,154.8
Assets — additional as-filed lines
+ Non-current Assets Held for Sale	8.9	13.3	0.0	0.0
Liabilities — additional as-filed lines
+ Liabilities of Disposal Group Held for Sale	0.5	0.0	0.0	0.0
Trade Payables — MSME split
+ Dues to Micro & Small — Current	—	21.6	54.2	54.2
+ Dues to Other Creditors — Current	—	432.7	490.1	490.1

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.